グルコース依存性インスリン分泌性受容体の世界市場 2020年

• 英文タイトル：Global Glucose Dependent Insulinotropic Receptor Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201111434 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、グルコース依存性インスリン分泌性受容体の世界市場を調査対象にし、グルコース依存性インスリン分泌性受容体の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他）、用途別分析（2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Amgen Inc、Kowa Co Ltd、Dong-A Socio Holdings Co Ltd、Arena Pharmaceuticals Inc、Hyundai Pharmaceutical Co Ltd、CymaBay Therapeutics Inc、Novartis AG、GlaxoSmithKline Plc、F. Hoffmann-La Roche Ltd、Merck & Co Inc、Taisho Pharmaceutical Holdings Co Ltd、Takeda Pharmaceutical Co Ltd、Yuhan Corp ・メーカー別販売量、売上、市場シェア ・グルコース依存性インスリン分泌性受容体の地域別市場分析 ・グルコース依存性インスリン分泌性受容体の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・グルコース依存性インスリン分泌性受容体のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・グルコース依存性インスリン分泌性受容体のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・グルコース依存性インスリン分泌性受容体の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・グルコース依存性インスリン分泌性受容体の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・グルコース依存性インスリン分泌性受容体の種類別市場規模2015-2020：DA-1241、GSK-2041706、HD-0471042、HD-0471953、HOB-047、MBX-2982、その他 ・グルコース依存性インスリン分泌性受容体の用途別市場規模2015-2020：2型糖尿病、肥満、慢性閉塞性肺疾患（COPD）、脂質異常症、その他 ・グルコース依存性インスリン分泌性受容体の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論

Market Overview
The global Glucose Dependent Insulinotropic Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Glucose Dependent Insulinotropic Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Glucose Dependent Insulinotropic Receptor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Glucose Dependent Insulinotropic Receptor market has been segmented into
DA-1241
GSK-2041706
HD-0471042
HD-0471953
HOB-047
MBX-2982
Others

By Application, Glucose Dependent Insulinotropic Receptor has been segmented into:
Type 2 Diabetes
Obesity
Chronic Obstructive Pulmonary Disease (COPD)
Dyslipidemia
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glucose Dependent Insulinotropic Receptor market presented in the report. This section sheds light on the sales growth of different regional and country-level Glucose Dependent Insulinotropic Receptor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glucose Dependent Insulinotropic Receptor market.

The report offers in-depth assessment of the growth and other aspects of the Glucose Dependent Insulinotropic Receptor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Glucose Dependent Insulinotropic Receptor Market Share Analysis
Glucose Dependent Insulinotropic Receptor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Glucose Dependent Insulinotropic Receptor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glucose Dependent Insulinotropic Receptor sales, revenue and market share for each player covered in this report.

The major players covered in Glucose Dependent Insulinotropic Receptor are:
Amgen Inc
Kowa Co Ltd
Dong-A Socio Holdings Co Ltd
Arena Pharmaceuticals Inc
Hyundai Pharmaceutical Co Ltd
CymaBay Therapeutics Inc
Novartis AG
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd
Merck & Co Inc
Taisho Pharmaceutical Holdings Co Ltd
Takeda Pharmaceutical Co Ltd
Yuhan Corp

Among other players domestic and global, Glucose Dependent Insulinotropic Receptor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucose Dependent Insulinotropic Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glucose Dependent Insulinotropic Receptor, with price, sales, revenue and global market share of Glucose Dependent Insulinotropic Receptor in 2018 and 2019.
Chapter 3, the Glucose Dependent Insulinotropic Receptor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucose Dependent Insulinotropic Receptor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Glucose Dependent Insulinotropic Receptor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Glucose Dependent Insulinotropic Receptor sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Glucose Dependent Insulinotropic Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucose Dependent Insulinotropic Receptor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 DA-1241
1.2.3 GSK-2041706
1.2.4 HD-0471042
1.2.5 HD-0471953
1.2.6 HOB-047
1.2.7 MBX-2982
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucose Dependent Insulinotropic Receptor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Type 2 Diabetes
1.3.3 Obesity
1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
1.3.5 Dyslipidemia
1.3.6 Others
1.4 Overview of Global Glucose Dependent Insulinotropic Receptor Market
1.4.1 Global Glucose Dependent Insulinotropic Receptor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Amgen Inc Details
2.1.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen Inc SWOT Analysis
2.1.4 Amgen Inc Product and Services
2.1.5 Amgen Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kowa Co Ltd
2.2.1 Kowa Co Ltd Details
2.2.2 Kowa Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kowa Co Ltd SWOT Analysis
2.2.4 Kowa Co Ltd Product and Services
2.2.5 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dong-A Socio Holdings Co Ltd
2.3.1 Dong-A Socio Holdings Co Ltd Details
2.3.2 Dong-A Socio Holdings Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Dong-A Socio Holdings Co Ltd SWOT Analysis
2.3.4 Dong-A Socio Holdings Co Ltd Product and Services
2.3.5 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arena Pharmaceuticals Inc
2.4.1 Arena Pharmaceuticals Inc Details
2.4.2 Arena Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arena Pharmaceuticals Inc SWOT Analysis
2.4.4 Arena Pharmaceuticals Inc Product and Services
2.4.5 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hyundai Pharmaceutical Co Ltd
2.5.1 Hyundai Pharmaceutical Co Ltd Details
2.5.2 Hyundai Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hyundai Pharmaceutical Co Ltd SWOT Analysis
2.5.4 Hyundai Pharmaceutical Co Ltd Product and Services
2.5.5 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 CymaBay Therapeutics Inc
2.6.1 CymaBay Therapeutics Inc Details
2.6.2 CymaBay Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 CymaBay Therapeutics Inc SWOT Analysis
2.6.4 CymaBay Therapeutics Inc Product and Services
2.6.5 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis AG SWOT Analysis
2.7.4 Novartis AG Product and Services
2.7.5 Novartis AG Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline Plc
2.8.1 GlaxoSmithKline Plc Details
2.8.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline Plc SWOT Analysis
2.8.4 GlaxoSmithKline Plc Product and Services
2.8.5 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche Ltd
2.9.1 F. Hoffmann-La Roche Ltd Details
2.9.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.9.4 F. Hoffmann-La Roche Ltd Product and Services
2.9.5 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck & Co Inc
2.10.1 Merck & Co Inc Details
2.10.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck & Co Inc SWOT Analysis
2.10.4 Merck & Co Inc Product and Services
2.10.5 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Taisho Pharmaceutical Holdings Co Ltd
2.11.1 Taisho Pharmaceutical Holdings Co Ltd Details
2.11.2 Taisho Pharmaceutical Holdings Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Taisho Pharmaceutical Holdings Co Ltd SWOT Analysis
2.11.4 Taisho Pharmaceutical Holdings Co Ltd Product and Services
2.11.5 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda Pharmaceutical Co Ltd
2.12.1 Takeda Pharmaceutical Co Ltd Details
2.12.2 Takeda Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda Pharmaceutical Co Ltd SWOT Analysis
2.12.4 Takeda Pharmaceutical Co Ltd Product and Services
2.12.5 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Yuhan Corp
2.13.1 Yuhan Corp Details
2.13.2 Yuhan Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Yuhan Corp SWOT Analysis
2.13.4 Yuhan Corp Product and Services
2.13.5 Yuhan Corp Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Glucose Dependent Insulinotropic Receptor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glucose Dependent Insulinotropic Receptor Manufacturer Market Share in 2019
3.3.2 Top 6 Glucose Dependent Insulinotropic Receptor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Glucose Dependent Insulinotropic Receptor Sales, Revenue and Market Share by Regions
4.1.1 Global Glucose Dependent Insulinotropic Receptor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Regions (2015-2020)
4.2 North America Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
4.3 Europe Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
4.5 South America Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Glucose Dependent Insulinotropic Receptor Sales, Revenue and Market Share by Country
5.1.1 North America Glucose Dependent Insulinotropic Receptor Sales and Market Share by Country (2015-2020)
5.1.2 North America Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Country (2015-2020)
5.2 United States Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
5.3 Canada Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
5.4 Mexico Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Glucose Dependent Insulinotropic Receptor Sales, Revenue and Market Share by Country
6.1.1 Europe Glucose Dependent Insulinotropic Receptor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Country (2015-2020)
6.2 Germany Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
6.3 UK Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
6.4 France Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
6.5 Russia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
6.6 Italy Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Regions (2015-2020)
7.2 China Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
7.3 Japan Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
7.4 Korea Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
7.5 India Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
7.7 Australia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Glucose Dependent Insulinotropic Receptor Sales, Revenue and Market Share by Country
8.1.1 South America Glucose Dependent Insulinotropic Receptor Sales and Market Share by Country (2015-2020)
8.1.2 South America Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
8.3 Argentina Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Glucose Dependent Insulinotropic Receptor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
9.3 Turkey Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
9.4 Egypt Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
9.5 South Africa Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Glucose Dependent Insulinotropic Receptor Sales and Market Share by Type (2015-2020)
10.2 Global Glucose Dependent Insulinotropic Receptor Revenue and Market Share by Type (2015-2020)
10.3 Global Glucose Dependent Insulinotropic Receptor Price by Type (2015-2020)
11 Global Glucose Dependent Insulinotropic Receptor Market Segment by Application
11.1 Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Application (2015-2020)
11.2 Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application (2015-2020)
11.3 Global Glucose Dependent Insulinotropic Receptor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Glucose Dependent Insulinotropic Receptor Sales, Revenue and Growth Rate (2021-2025)
12.2 Glucose Dependent Insulinotropic Receptor Market Forecast by Regions (2021-2025)
12.2.1 North America Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025)
12.2.2 Europe Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025)
12.2.4 South America Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025)
12.3 Glucose Dependent Insulinotropic Receptor Market Forecast by Type (2021-2025)
12.3.1 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Type (2021-2025)
12.3.2 Global Glucose Dependent Insulinotropic Receptor Market Share Forecast by Type (2021-2025)
12.4 Glucose Dependent Insulinotropic Receptor Market Forecast by Application (2021-2025)
12.4.1 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Application (2021-2025)
12.4.2 Global Glucose Dependent Insulinotropic Receptor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Glucose Dependent Insulinotropic Receptor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Glucose Dependent Insulinotropic Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Glucose Dependent Insulinotropic Receptor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Inc Glucose Dependent Insulinotropic Receptor Major Business
Table 9. Amgen Inc Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 10. Amgen Inc SWOT Analysis
Table 11. Amgen Inc Glucose Dependent Insulinotropic Receptor Product and Services
Table 12. Amgen Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Kowa Co Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Major Business
Table 15. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 16. Kowa Co Ltd SWOT Analysis
Table 17. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product and Services
Table 18. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Dong-A Socio Holdings Co Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Major Business
Table 21. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 22. Dong-A Socio Holdings Co Ltd SWOT Analysis
Table 23. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Services
Table 24. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Arena Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 26. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Major Business
Table 27. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 28. Arena Pharmaceuticals Inc SWOT Analysis
Table 29. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product and Services
Table 30. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Hyundai Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Major Business
Table 33. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 34. Hyundai Pharmaceutical Co Ltd SWOT Analysis
Table 35. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Services
Table 36. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. CymaBay Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 38. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Major Business
Table 39. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 40. CymaBay Therapeutics Inc SWOT Analysis
Table 41. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product and Services
Table 42. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis AG Glucose Dependent Insulinotropic Receptor Major Business
Table 45. Novartis AG Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 46. Novartis AG SWOT Analysis
Table 47. Novartis AG Glucose Dependent Insulinotropic Receptor Product and Services
Table 48. Novartis AG Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Major Business
Table 51. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 52. GlaxoSmithKline Plc SWOT Analysis
Table 53. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product and Services
Table 54. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 56. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Major Business
Table 57. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 58. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 59. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product and Services
Table 60. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Major Business
Table 63. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 64. Merck & Co Inc SWOT Analysis
Table 65. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product and Services
Table 66. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Taisho Pharmaceutical Holdings Co Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Major Business
Table 69. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 70. Taisho Pharmaceutical Holdings Co Ltd SWOT Analysis
Table 71. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product and Services
Table 72. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Takeda Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Major Business
Table 75. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 76. Takeda Pharmaceutical Co Ltd SWOT Analysis
Table 77. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product and Services
Table 78. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Yuhan Corp Basic Information, Manufacturing Base and Competitors
Table 80. Yuhan Corp Glucose Dependent Insulinotropic Receptor Major Business
Table 81. Yuhan Corp Glucose Dependent Insulinotropic Receptor Total Revenue (USD Million) (2018-2019)
Table 82. Yuhan Corp SWOT Analysis
Table 83. Yuhan Corp Glucose Dependent Insulinotropic Receptor Product and Services
Table 84. Yuhan Corp Glucose Dependent Insulinotropic Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Glucose Dependent Insulinotropic Receptor Sales by Manufacturer (2018-2019) (K Pcs)
Table 86. Global Glucose Dependent Insulinotropic Receptor Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Glucose Dependent Insulinotropic Receptor Sales by Regions (2015-2020) (K Pcs)
Table 88. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Regions (2015-2020)
Table 89. Global Glucose Dependent Insulinotropic Receptor Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Glucose Dependent Insulinotropic Receptor Sales by Countries (2015-2020) (K Pcs)
Table 91. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2015-2020)
Table 92. North America Glucose Dependent Insulinotropic Receptor Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2015-2020)
Table 94. Europe Glucose Dependent Insulinotropic Receptor Sales by Countries (2015-2020) (K Pcs)
Table 95. Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2015-2020)
Table 96. Europe Glucose Dependent Insulinotropic Receptor Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales by Regions (2015-2020) (K Pcs)
Table 98. Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Glucose Dependent Insulinotropic Receptor Sales by Countries (2015-2020) (K Pcs)
Table 101. South America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2015-2020)
Table 102. South America Glucose Dependent Insulinotropic Receptor Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Glucose Dependent Insulinotropic Receptor Sales by Countries (2015-2020) (K Pcs)
Table 105. Middle East & Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2015-2020)
Table 108. Global Glucose Dependent Insulinotropic Receptor Sales by Type (2015-2020) (K Pcs)
Table 109. Global Glucose Dependent Insulinotropic Receptor Sales Share by Type (2015-2020)
Table 110. Global Glucose Dependent Insulinotropic Receptor Revenue by Type (2015-2020) (USD Million)
Table 111. Global Glucose Dependent Insulinotropic Receptor Revenue Share by Type (2015-2020)
Table 112. Global Glucose Dependent Insulinotropic Receptor Sales by Application (2015-2020) (K Pcs)
Table 113. Global Glucose Dependent Insulinotropic Receptor Sales Share by Application (2015-2020)
Table 114. Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Regions (2021-2025) (K Pcs)
Table 115. Global Glucose Dependent Insulinotropic Receptor Market Share Forecast by Regions (2021-2025)
Table 116. Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Type (2021-2025) (K Pcs)
Table 117. Global Glucose Dependent Insulinotropic Receptor Market Share Forecast by Type (2021-2025)
Table 118. Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Application (2021-2025)
Table 119. Global Glucose Dependent Insulinotropic Receptor Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Glucose Dependent Insulinotropic Receptor Picture
Figure 2. Global Sales Market Share of Glucose Dependent Insulinotropic Receptor by Type in 2019
Figure 3. DA-1241 Picture
Figure 4. GSK-2041706 Picture
Figure 5. HD-0471042 Picture
Figure 6. HD-0471953 Picture
Figure 7. HOB-047 Picture
Figure 8. MBX-2982 Picture
Figure 9. Others Picture
Figure 10. Glucose Dependent Insulinotropic Receptor Sales Market Share by Application in 2018
Figure 11. Type 2 Diabetes Picture
Figure 12. Obesity Picture
Figure 13. Chronic Obstructive Pulmonary Disease (COPD) Picture
Figure 14. Dyslipidemia Picture
Figure 15. Others Picture
Figure 16. Global Glucose Dependent Insulinotropic Receptor Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Glucose Dependent Insulinotropic Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Manufacturer in 2019
Figure 37. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Glucose Dependent Insulinotropic Receptor Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Glucose Dependent Insulinotropic Receptor Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 42. Global Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Regions (2015-2020)
Figure 44. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Regions in 2018
Figure 45. North America Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
Figure 46. Europe Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
Figure 48. South America Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020)
Figure 50. North America Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2015-2020)
Figure 52. North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries in 2018
Figure 53. North America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries in 2018
Figure 55. United States Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Canada Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Mexico Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Europe Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries in 2019
Figure 61. Germany Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. UK Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. France Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Russia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Italy Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Glucose Dependent Insulinotropic Receptor Revenue Market Share by Regions 2019
Figure 69. China Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Korea Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. India Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Southeast Asia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. South America Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries in 2019
Figure 76. South America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries in 2019
Figure 77. Brazil Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Argentina Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Egypt Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Turkey Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. South Africa Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. Global Glucose Dependent Insulinotropic Receptor Sales and Growth Rate (2021-2025) (K Pcs)
Figure 88. Global Glucose Dependent Insulinotropic Receptor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025) (K Pcs)
Figure 90. Europe Sales Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025) (K Pcs)
Figure 91. Asia-Pacific Sales Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025) (K Pcs)
Figure 92. South America Sales Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025) (K Pcs)
Figure 93. Middle East & Africa Sales Glucose Dependent Insulinotropic Receptor Market Forecast (2021-2025) (K Pcs)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel

---